Using Simulation to Improve Drug-Delivery Effectiveness - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Using Simulation to Improve Drug-Delivery Effectiveness
Pharmaceutical companies are responding to the high cost of introducing new drugs to market in different ways.


Pharmaceutical Technology
pp. 38-42

References

1. C.P. Adams and V.V. Brantner, Health Aff. 25 (2) 420–428 (2006).

2. H. Schubert, Chem. Ing. Tech. 51 (4) 266–277 (1979).

3. J. Visser, Powder Tech., 58 (1) P1–1- (1989).

4. H. Krupp, Adv. Colloid Int. Sci. 1 (2) 111–239 (1967).

5. D.H. Geroski and H.F. Edelhauser, IOVS 41 (5) 961–964 (2000).

6. P.J. Missel, M. Horner, and R. Muralikrishnan, Pharm Res., 27 (8) 1530–1546 (2010).

7. R. K. Balachandran and V.H. Barocas, Pharm Res. 25 (11) 2685–2696 (2008).

8. S. Kandavilli, V. Nair, and R. Panchagnula, Pharm. Technol. 26 (4) 62–80 (2002).

9. J.E. Rim, P.M. Pinsky, and W.W. van Osdol, Annals Biomed. Eng. 33 (10) 1422–1438 (2005).

10. M. Horner, Desktop Eng., April 1, 2011, http://www.deskeng.com/articles/aabamz.htm.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here